**Trader consensus favoring "No" at 94.5% reflects the absence of any new pathogen meeting pandemic criteria through September 2026, despite the WHO-declared PHEIC for the Bundibugyo virus Ebola outbreak in the DRC and Uganda.** This largest recorded BVD event, with several thousand confirmed cases and high fatality rates in affected provinces, has prompted coordinated international surveillance, contact tracing, and initial vaccination efforts, yet transmission remains limited to direct bodily fluid contact with low importation risk outside the region per ECDC and CDC assessments. Ongoing moderate COVID-19 circulation, mpox clusters, cholera, and measles outbreaks represent established or localized threats without the sustained global human-to-human spread or novel characteristics required for a new pandemic declaration. With four months remaining and no model consensus projecting worldwide escalation from current events, market-implied odds align with historical patterns where regional hemorrhagic fever outbreaks rarely achieve pandemic scale under modern public health frameworks. Sudden emergence of a high-transmissibility respiratory pathogen or major control failures could still shift probabilities.